Big news on Corona Vaccine: KoviShield and indigenous Kovacine have final approval, Modi said – a matter of pride for every Indian

The wait of the people of the country for the Corona vaccine is over. Indigenous Kovaxin of Bharat Biotech and the Emergency Use of Kovshield of Serum Institute have been approved by the Drugs Controller General of India (DCGI). On the other hand, Zaykov-D of Zydus Cadila Healthcare has been approved for Phase-3 trial. DCGI gave this information at a press conference on Sunday.

The Subject Expert Committee on Corona on Saturday prescribed restrictive endorsement of Bharat Biotech to Covaxin for crisis use. Prior on Friday, the CoviShield of the Serum Institute was prescribed to give a comparative endorsement. With the endorsement of both, it is currently expected that the immunization drive will begin from this week itself. Immunization dry run has additionally begun in the whole nation to test the arrangements.


PM Modi Tweet –

It would make every Indian proud that the two vaccines that have been given emergency use approval are made in India! This shows the eagerness of our scientific community to fulfil the dream of an Aatmanirbhar Bharat, at the root of which is care and compassion.

Related posts

New drugs can be used to prevent and treat corona

Sam Vinayak

Vaccine update: More than 1.26 crore doses of vaccine have been rolled out in the country so far


DCGI approved the emergency use of Kovishield and Kovaxin

Anoop Kamboj

Government orders 1.10 crore doses from serum

Anoop Kamboj

The future of the country will have to be given priority over the elderly for medicine

Sam Vinayak

Developed a drug capable of stopping corona and its variants

Sam Vinayak